Development and Characterization of In Situ Oral Gel of Spiramycin
Figure 8
Different concentrations of spiramycin loaded in situ gels incubated with Staphylococcus aureus and E. coli, respectively (where dilutions are referred to as 50 mg/mL, 2.25 mg/mL, 6.25 mg/mL, and 5.0 mg/mL).
